Restless legs syndrome: Clinical experience with long-term treatment

Sleep Medicine

Volumn 5, Issue 5, 2004, Pages 495-500

  Clavadetscher, Sandra C ^a   Gugger, Matthias ^a   Bassetti, Claudio L ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Efficacy; Polysomnography; Predictors

Indexed keywords

CLONAZEPAM; GABAPENTIN; LEVODOPA; OPIATE; PERGOLIDE; PRAMIPEXOLE;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FOLLOW UP; GENDER; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PREDICTION; PRIORITY JOURNAL; RATING SCALE; RESTLESS LEGS SYNDROME; SCORING SYSTEM; SYMPTOMATOLOGY;

ADULT; AGED; AMINES; CLONAZEPAM; CYCLOHEXANECARBOXYLIC ACIDS; DOPAMINE AGONISTS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GAMMA-AMINOBUTYRIC ACID; HUMANS; LEVODOPA; LONG-TERM CARE; MALE; MIDDLE AGED; NARCOTICS; PROSPECTIVE STUDIES; RESTLESS LEGS SYNDROME; TREATMENT OUTCOME;

EID: 4444356431     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2004.05.006     Document Type: Article

References (19)

1. K. Ekbom Restless legs syndrome Neurology 10 1960 868-873
2. G. Lavigne J. Montplaisir Restless legs syndrome and sleep bruxism: prevalence and association among canadians Sleep 17 1994 739-743
3. A. Walters The International Restless Legs Syndrome Study Group Toward a better definition of the restless legs syndrome Mov Disord 10 1995 634-642
4. W. Hening R. Allen C. et al. Earley The treatment of restless legs syndrome and periodic limb movement disorder Sleep 22 7 1999 970-999
5. C. Von Scheele V. Kempi Long-term effect of dopaminergic drugs in restless legs: a two-year follow-up Arch Neurol 47 1990 1223-1224
6. M. Silber J.J. Shepard J. Wisbey Pergolide in the management of restless legs syndrome: an extended study Sleep 20 10 1997 878-882
7. K. Stiasny T.C. Wetter Long-term effects of pergolide in the treatment of restless legs syndrome Neurology 56 10 2001 1399-1402
8. H. Lauerma J. Markkula Treatment of restless legs syndome with tramadol: an open study J Clin Psychiatr 60 4 1999 241-244
9. R. Godbout J. Montplaisir G. Poirier Epidemiological data in familial restless legs syndrome [abstract] Sleep Res 16 1987 338
10. W. Ondo J. Jankovic Restless legs syndrome: clinicoetiologic correlates Neurology 47 1996 1435-1441
11. M. Johns A new method for measuring daytime sleepiness: the Epworth sleepiness scale Sleep 14 6 1991 540-545
12. W.A. Hening A.S. Walters The international RLS study group rating scale: a reliable and valid instrument for assessing severity of the restless legs syndrome Neurology 56 Suppl 3 2001 A4
13. C. Bassetti D. Mauerhofer M. Gugger et al. Restless legs syndrome: a clinical study of 55 patients Eur Neurol 45 2001 57-74
14. C. Trenkwalder K. Stiasny l -dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial Sleep 18 8 1995 681-688
15. M.H. Silber M. Girish R. Izurieta Pramipexole in the management of restless legs syndrome: an extended study Sleep 26 2003 819 -821
16. C. Trenkwalder V.C. Seidel J. Kazenwdel et al. One-year treatment with standard and sustained-release levodopa: appropriate long-term treatment of restless legs syndrome Mov Dis 18 2003 1184-1189
17. J. Montplaisir R. Denesle D. Petit Pramipexole in the treatment of restless legs syndrome: a follow-up study Eur J Neurol 7 Suppl 1 2000 27-31
18. R. Broughton M.A. Tolentino M. Krelina Excessive fragmentary mycoclonus in NREM sleep: a report of 36 cases Electroencephalogr Clin Neurophysiol 61 1985 123-133
19. C. Bassetti S. Clavadetscher M. Gugger C.W. Hess Pergolide-associated sleep attacks a patient with restless legs syndrome Sleep Med 3 2002 275-277